Y. Takeuchi

Effect of metoclopramide on muscle sympathetic nerve activity in humans.

Y. Sugiyama, T. Mano, T. Matsukawa, 1993, Journal of the autonomic nervous system.

CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.

G. Sobue, N. Atsuta, M. Katsuno, 2007, Brain : a journal of neurology.

Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials

G. Sobue, M. Katsuno, A. Hirakawa, 2019, Journal of Neurology.

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

S. Tsuji, G. Sobue, M. Morita, 2010, The Lancet Neurology.

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

G. Sobue, N. Atsuta, M. Katsuno, 2009, Annals of neurology.

The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy

G. Sobue, M. Katsuno, Tomohiko Nakamura, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Walking capacity evaluated by the 6‐minute walk test in spinal and bulbar muscular atrophy

G. Sobue, N. Atsuta, M. Katsuno, 2008, Muscle & nerve.

Molecular genetics and biomarkers of polyglutamine diseases.

G. Sobue, M. Katsuno, H. Adachi, 2008, Current molecular medicine.

Therapeutic strategies for spinal and bulbar muscular atrophy (SBMA)

G. Sobue, M. Katsuno, H. Adachi, 2007 .